IDEX REPORTS THIRD QUARTER RESULTS

News Release
October 29, 2024

Third Quarter 2024 Highlights
(All comparisons are against the third quarter of 2023 unless otherwise noted)

  • Sales of $798 million, up 1% overall and flat organically
  • Reported diluted EPS of $1.57, down 43%, and adjusted diluted EPS of $1.90, down 10%
  • Operating cash flow of $205 million, down 9%; and 172% of net income, up from 108%
  • Free cash flow of $192 million, down 7%; and 133% of adjusted net income, up from 129%
  • Completed acquisition of Mott Corporation on September 5, 2024
  • Completed a public offering of $500 million principal amount of 4.950% Senior Notes, due
    September 2029

Full Year 2024 Outlook

  • Full year organic sales growth is projected to decline 1% to 2% versus the prior year
  • Full year GAAP diluted EPS of $6.65 – $6.70 vs. previous guidance of $6.85 – $6.95. Current
    guidance includes purchase accounting impacts, such as acquisition-related amortization, from
    the acquisition of Mott Corporation
  • Adjusted diluted EPS of $7.85 – $7.90 vs. previous guidance of $7.80 – $7.90

NORTHBROOK, IL, October 29, 2024 – IDEX Corporation (NYSE: IEX) today announced its
financial results for the three-month period ended September 30, 2024.

“We are encouraged by our third quarter performance. The teams within our Fluid & Metering
Technologies and Fire & Safety / Diversified Products segments drove organic growth against an
uncertain economic backdrop while delivering strong margins through operational execution,” said Eric D.
Ashleman, IDEX Corporation Chief Executive Officer and President. “We saw a healthy organic increase
in orders within our Health & Science Technologies segment, strengthening our business positioning as
we look for signs of extended recovery within the life science and semiconductor sectors.”

“Meanwhile, less than two months since completing our acquisition of Mott, the partnership is off to a fast start. Teams from other IDEX businesses are already collaborating with their Mott colleagues, designing new prototypes together that incorporate Mott’s highly engineered filtration products. Talented IDEX employees have been integrated into Mott leadership since closing, helping initiate a smooth integration,” Ashleman said. “The core advanced technology markets Mott serves, including semiconductor wafer fabrication, transformative energy solutions, medical technologies, and water purification, are advantaged to outperform over the long haul.”

“IDEX remains well-positioned, solving difficult problems with customers on the cutting edge of new
technologies. We expect to continue deploying resources across our portfolio with our 8020 mindset
toward growth accelerators to position us to drive long-term value creation.”

View full version here.

IDEX Corporation Completes Acquisition of Mott Corporation

News Release
September 5, 2024

NORTHBROOK, Illinois – September 5, 2024 – IDEX Corporation (NYSE: IEX) (“IDEX”) has completed its previously-announced acquisition of Mott Corporation and its subsidiaries (“Mott”), expanding IDEX’s applied material science technology capabilities in high-value end markets.

Mott is a leader in the design and manufacturing of sintered porous material structures and flow control solutions, with deep applied material science knowledge and process control capabilities. For more than 60 years, Mott has solved complex engineering challenges by innovating with global OEMS and leading technology brands to develop cutting-edge technologies.

As part of IDEX’s Health & Science Technologies segment, Mott is expected to:

  • Enhance the ability to deliver innovative, customized, and highly technical micro-precision solutions that are increasingly essential to customer product performance.
  • Increase opportunities in semiconductor wafer fabrication equipment, energy transition, medical technologies, space & defense, and water purification industries.
  • Complement the successful integrations of the Muon Group, Iridian Spectral Technologies, and STC Material Solutions, providing unique process-based capabilities working with specialized materials.
  • Drive near- and long-term value creation through implementation of 8020 and the IDEX Operating Model.

“The acquisition of Mott brings scale to our growing suite of material science technology capabilities and amplifies our ability to partner with customers to develop innovative solutions,” said Eric D. Ashleman, Chief Executive Officer and President of IDEX. “This is an important step in our strategy to deliver long-term, compounding value to our customers, employees, and shareholders. I’m pleased to welcome the Mott team to the IDEX family.”

About IDEX

IDEX Corporation (NYSE: IEX) designs and builds engineered products and mission-critical components that make everyday life better. IDEX precision components help craft the microchip powering your electronics, treat water so it is safe to drink, and protect communities and the environment from sewer overflows. Our optics enable communications across outer space, and our pumps move challenging fluids that range from hot, to viscous, to caustic. IDEX components assist healthcare professionals in saving lives as part of many leading diagnostic machines, including DNA sequencers that help doctors personalize treatment. And our fire and rescue tools, including the industry-leading Hurst Jaws of Life®, are trusted by rescue workers around the world. These are just some of the thousands of products that help IDEX live its purpose – Trusted Solutions, Improving Lives. Founded in 1988 with three small, entrepreneurial manufacturing companies, IDEX now includes more than 50 diverse businesses around the world. With about 8,800 employees and manufacturing operations in more than 20 countries, IDEX is a diversified, high-performing, global company with approximately $3.3 billion in annual sales.

For further information on IDEX Corporation and its business units, visit the company’s website at www.idexcorp.com

Cautionary Note Regarding Forward-Looking Statements

This press release contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Such forward-looking statements include statements regarding the expected benefits of the acquisition of Mott, the expected impact of the acquisition on IDEX’s product offerings or proposed product offerings, IDEX’s combined existing and new customers and access to high-value end markets, the enhancement of IDEX’s business strategy, integration plans, the expected growth opportunities, and the anticipated long-term value to IDEX’s shareholders and customers resulting from the acquisition. These statements are subject to inherent uncertainties and risks that could cause actual results to differ materially from those anticipated at the date of this press release. The risks and uncertainties include, but are not limited to, the following: levels of industrial activity and economic conditions in the U.S. and other countries around the world, including uncertainties in the financial markets; pricing pressures, including inflation and rising interest rates and other competitive factors and levels of capital spending in certain industries; the impact of catastrophic weather events, natural disasters and public health threats; economic and political consequences resulting from terrorist attacks and wars; IDEX’s ability to integrate Mott and to acquire, integrate and operate other acquired businesses on a profitable basis; cybersecurity incidents; the relationship of the U.S. dollar to other currencies and its impact on pricing and cost competitiveness; political and economic conditions in foreign countries in which IDEX operates; developments with respect to trade policy and tariffs; interest rates; capacity utilization and the effect this has on costs; labor markets; supply chain conditions; market conditions and material costs; risks related to environmental, social and corporate governance issues, including those related to climate change and sustainability; and developments with respect to contingencies, such as litigation and environmental matters.  Additional factors that could cause actual results to differ materially from those reflected in the forward-looking statements include, but are not limited to, the risks discussed in the “Risk Factors” section included in IDEX’s most recent annual report on Form 10-K and IDEX’s subsequent quarterly reports filed with the Securities and Exchange Commission (“SEC”) and the other risks discussed in IDEX’s filings with the SEC. The forward-looking statements included here are only made as of the date of this press release and management undertakes no obligation to publicly update them to reflect subsequent events or circumstances, except as may be required by law. Investors are cautioned not to rely unduly on forward-looking statements when evaluating the information presented here.

Investor Contact:

Wendy Palacios

Vice President, FP&A and Investor Relations

(847) 457-3723

wpalacios@idexcorp.com

Media Contact:

Mark Spencer

Vice President, Global Communications

(847) 457-3793

mdspencer@idexcorp.com

IDEX Corporation Announces Pricing of Public Offering of Senior Notes

News Release
August 7, 2024

NORTHBROOK, Ill.–(BUSINESS WIRE)—August 7, 2024– IDEX Corporation (NYSE: IEX) (“IDEX” or the “company”) today announced the pricing of its public offering of $500 million principal amount of 4.950% Senior Notes due 2029. The notes will be unsecured senior obligations that rank equal in right of payment to all of IDEX’s existing and future senior indebtedness. Closing of the offering is expected to occur on August  21, 2024, subject to the satisfaction of customary closing conditions.

IDEX estimates that the net proceeds from the offering will be approximately $495.0 million, after deducting underwriting discounts and commissions and its estimated offering expenses. The company intends to use the net proceeds from this offering, together with available revolving credit facility borrowings and cash on hand, to (i) fund the cash consideration payable by IDEX to consummate its previously announced acquisition of all of the issued and outstanding capital stock of Mott Corporation and its subsidiaries and (ii) pay fees and expenses in respect of the foregoing.

Wells Fargo Securities, LLC, BofA Securities, Inc. and J.P. Morgan Securities LLC are acting as joint book-running managers for the offering.

IDEX is making this offering pursuant to a shelf registration statement that automatically became effective upon filing with the Securities and Exchange Commission (the “SEC”). This offering will be made solely by means of a prospectus and prospectus supplement. You may obtain a copy of the preliminary prospectus supplement, the accompanying prospectus and the final prospectus supplement, when available, for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, any underwriter or any dealer participating in the offering will arrange to send you any of those documents upon request by contacting the joint book-running managers at:

Wells Fargo Securities, LLC, 608 2nd Avenue South, Suite 1000, Minneapolis, Minnesota 55402, Attn: WFS Customer Service; Telephone (800) 645-3751 or Email: wfscustomerservice@wellsfargo.com

BofA Securities, Inc., 201 North Tryon Street (NC1-022-02-25), Charlotte, North Carolina 28255-0001, Attn: Prospectus Department; Telephone: (800) 294-1322 or Email: dg.prospectus_requests@bofa.com

J.P. Morgan Securities LLC, 383 Madison Avenue, New York, New York, 10179, Attn: Investment Grade Syndicate Desk, 3rd Floor; Telephone: (212) 834-4533.

This press release shall not constitute a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which  such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.

Forward-Looking Statements

This press release contains “forward-looking” statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements relate to, among other things, expectations regarding the anticipated closing of the notes offering and IDEX’s intended use of net proceeds therefrom. Statements which are not historical facts and relate to future plans, events or performance are forward-looking statements that are based upon management’s current expectations and are subject to risks and uncertainties. The forward-looking statements are based on management’s current expectations and should not be construed in any manner as a guarantee that such events or results will in fact occur. All forward-looking statements speak only as of the date of this press release and IDEX undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Detailed information regarding risk factors with respect to IDEX and the offering are included in the company’s filings with the SEC, including the prospectus and prospectus supplement for the offering. The forward-looking statements included here are only made as of the date of this press release, and management undertakes no obligation to publicly update them to reflect subsequent events or circumstances, except as may be required by law. Investors are cautioned not to rely unduly on forward-looking statements when evaluating the information presented here. Any such forward-looking statements are not guarantees of future performances and actual results, developments and business decisions may differ from those contemplated by such forward-looking statements.

About IDEX

IDEX Corporation (NYSE: IEX) designs and builds engineered products and mission-critical components that make everyday life better. IDEX precision components help craft the microchip powering your electronics, treat water so it is safe to drink, and protect communities and the environment from sewer overflows. Our optics enable communications across outer space, and our pumps move challenging fluids that range from hot, to viscous, to caustic. IDEX components assist healthcare professionals in saving lives as part of many leading diagnostic machines, including DNA sequencers that help doctors personalize treatment. And our fire and rescue tools, including the industry-leading Hurst Jaws of Life®, are trusted by rescue workers around the world. These are just some of the thousands of products that help IDEX live its purpose – Trusted Solutions, Improving Lives™. Founded in 1988 with three small, entrepreneurial manufacturing companies, IDEX now includes more than 50 diverse businesses around the world. With about 8,800 employees and manufacturing operations in more than 20 countries, IDEX is a diversified, high-performing, global company with approximately $3.3 billion in annual sales.

Investor Contact:

Wendy Palacios
Vice President FP&A and Investor Relations
+1 847.457.3723
investorrelations@idexcorp.com

Source: IDEX Corporation

IDEX REPORTS SECOND QUARTER RESULTS AND UPDATES 2024 OUTLOOK

News Release
July 31, 2024

Second Quarter 2024 Highlights
(All comparisons are against the second quarter of 2023 unless otherwise noted)

  • Sales of $807 million, down 5% overall and 4% organically
  • Reported diluted EPS of $1.86, up 2%, and adjusted diluted EPS of $2.06, down 6%, exceeding
    second quarter expectations
  • Operating cash flow of $134 million, down 5%; free cash flow of $118 million, down 2%

Revised Full Year and Third Quarter 2024 Outlook

  • Full year organic sales growth is projected to decline 1% to 2% versus the prior year, down from
    previous guidance of an increase of 0% to 2%
  • Full year GAAP diluted EPS of $6.85 – $6.95 (adjusted diluted EPS of $7.80 – $7.90), down from
    previous guidance of $7.13 – $7.43 (adjusted diluted EPS of $8.15 – $8.45)
  • Third quarter organic sales are projected to be 0% to 1% over the prior year period
  • Third quarter GAAP diluted EPS of $1.61 – $1.66 (adjusted diluted EPS of $1.85 – $1.90)

NORTHBROOK, IL, July 31, 2024 – IDEX Corporation (NYSE: IEX) today announced its financial
results for the three-month period ended June 30, 2024.

“IDEX teams delivered strong execution in the second quarter, expanding margins sequentially despite
stronger uncertainty-fueled macro headwinds,” said Eric D. Ashleman, IDEX Corporation Chief Executive
Officer and President.
“As we tune the portfolio for sustained growth performance, our business leaders are deploying focused
resources to our best long term growth initiatives within attractive application areas. We are bolstering
those efforts through thoughtful and disciplined capital deployment. Our recently announced acquisition of Mott Corporation is a powerful example given its outstanding fit with our businesses and strategy.”

For further information on IDEX Corporation and its business units, visit the company’s website at
www.idexcorp.com.

View full version at at https://investors.idexcorp.com/news-releases/news-release-details/idex-reports-second-quarter-results-and-updates-2024-outlook

IDEX Corporation to Acquire Mott Corporation, Expanding Applied Materials Science Technology Capabilities Across High-Value End Markets

News Release
July 23, 2024
  • Enhances ability to deliver innovative, customized, and highly technical micro-precision solutions that are increasingly essential to customer product performance
  • Increases opportunities in semiconductor wafer fab equipment, energy transition, medical technologies, space & defense, and water purification industries
  • Complements successful integration of the Muon Group, Iridian Spectral Technologies, and STC Material Solutions, providing unique process-based capabilities working with specialized materials
  • Drives near- and long-term value creation through implementation of 8020 and the IDEX Operating Model

NORTHBROOK, Ill.–(BUSINESS WIRE)–July 23, 2024– IDEX Corporation (NYSE: IEX) (“IDEX”) today announced it has entered into a definitive agreement to acquire Mott Corporation and its subsidiaries (“Mott”) for cash consideration of $1 billion (the “transaction”), subject to customary adjustments. When adjusted for the present value of expected tax benefits of approximately $100 million, the net transaction value is approximately $900 million. This represents approximately 19x Mott’s forecasted full year 2024 EBITDA and a mid-teens multiple based on forecasted 2025 EBITDA. The transaction is expected to be accretive to adjusted earnings per share in fiscal year 2026.

Mott is a leader in the design and manufacturing of sintered porous material structures and flow control solutions, with deep applied material science knowledge and process control capabilities. For more than 60 years, Mott has solved highly complex engineering challenges by co-innovating with the world’s largest technical brands and OEMs in dynamic markets including semiconductor, energy, water, and space.

“Mott’s business fits the IDEX sweet spot of highly engineered, configurable mission-critical components focused on scalable select applications. The addition of Mott represents an important step in our evolution, as we continue building our differentiated capabilities in applied materials technologies. Mott brings advanced technical and application expertise that will expand our capabilities in high-value end markets and open new organic growth opportunities. Our focus on driving profitable growth through the enterprise-wide application of 80/20 is expected to yield material benefits,” said Eric D. Ashleman, Chief Executive Officer and President of IDEX. “The addition of Mott supports our strategy to deliver long-term, compounding value to our customers, employees, and shareholders, which includes targeted inorganic growth funded by strong cash flow generation. With shared cultural values, including a deep passion for solving customer challenges through technical capabilities and innovative solutions, our great teams combine to offer meaningful go-to-market opportunities. We look forward to welcoming the over 500 Mott employees to IDEX.”

Transaction Expected to Deliver Significant Strategic and Financial Benefits

Expands applied material science technologies portfolio: Brings scale to IDEX’s growing suite of focused, high-value businesses – including IDEX Optical Technologies, the Muon Group, and recently acquired Iridian Spectral Technologies and STC Material Solutions – that address customer demand for novel solutions and expertise across advanced materials, microscale features, precision components, and proprietary production processes.

Extends similar value proposition into new customer relationships: Like IDEX, Mott develops and delivers essential products and solutions that represent a modest cost relative to the scale of the overall systems and processes that they support. Mott’s strong tradition of innovating closely with OEM customers brings additive, long-term customer relationships, enabling efficient integration into the IDEX family.

Extends capabilities to address unique customer needs: Adds advanced customization and system-design capabilities, deepening IDEX’s position as an innovation partner. This allows IDEX to further address customer needs for extremely precise solutions in fluidic applications from the product to system-level, including the opportunity to offer tailored, cross-functional products. For example, we expect Mott, IDEX Health & Science, Muon, and our Material Processing Technologies businesses to find additive commercial and technology solutions for medical device, healthcare and biotech customers. Within transitioning energy markets, Mott and IDEX’s pneumatics businesses could bring operational and applications expertise to meet customer needs for more efficiency and lower carbon emissions.

Enhances positioning across high-value end markets: Bolsters ability to grow presence in select, technology-enabled applications with substantial growth potential, including across semiconductor wafer fab equipment, the energy transition, medical technologies, space & defense, and water purification.

Adds to long-term growth and margin profile: Combines the technical and commercial excellence of IDEX with leading-edge innovation, technology, and R&D expertise of Mott, which is anticipated to yield meaningful commercial growth synergies over the next three years and drive EBITDA expansion through the proven application of 80/20 as part of the IDEX Operating Model.

“We’re excited to join an industry leader with a strong record of helping customers solve their toughest problems. Mott brings applied material science, chemistry, and application expertise, an additive and complementary customer base, and a growing pipeline of opportunities. When combined with the scale of IDEX, industry-leading positions, and deep technological know-how, this will yield meaningful synergies and benefits. Our culture and capabilities align with IDEX, and our employees will add tremendous value to the company, just as they’ve driven Mott’s growth for generations.” said Boris Levin, President and Chief Executive Officer of Mott.

In 2024, Mott is expected to generate approximately $200 million of revenue, with an EBITDA margin in the low 20s. Mott will join IDEX’s Health & Science Technologies segment. The transaction will be funded through a combination of cash on hand, borrowings from IDEX’s current credit facility, and potential debt issuance, and it is expected to close by the end of the third quarter of 2024, subject to regulatory approvals and customary closing conditions.

Conference Call Information

IDEX will host a conference call to discuss the transaction at 9:30 am Central Time (CDT) today. The conference call will be webcast live from IDEX’s investor relations website at https://investors.idexcorp.com. The conference call can also be accessed live over the phone by dialing 1-877-709-8150 or +1 201-689-8354. The conference ID is 13747873. A replay will be available approximately three hours after the call and can be accessed by dialing 877-660-6853 or +1 201-612-7415 for international callers. The replay will be available through August 23, 2024.

About IDEX

IDEX Corporation (NYSE: IEX) designs and builds engineered products and mission-critical components that make everyday life better. IDEX precision components help craft the microchip powering your electronics, treat water so it is safe to drink, and protect communities and the environment from sewer overflows. Our optics enable communications across outer space, and our pumps move challenging fluids that range from hot, to viscous, to caustic. IDEX components assist healthcare professionals in saving lives as part of many leading diagnostic machines, including DNA sequencers that help doctors personalize treatment. And our fire and rescue tools, including the industry-leading Hurst Jaws of Life®, are trusted by rescue workers around the world. These are just some of the thousands of products that help IDEX live its purpose – Trusted Solutions, Improving Lives. Founded in 1988 with three small, entrepreneurial manufacturing companies, IDEX now includes more than 50 diverse businesses around the world. With about 8,800 employees and manufacturing operations in more than 20 countries, IDEX is a diversified, high-performing, global company with approximately $3.3 billion in annual sales.

For further information on IDEX Corporation and its business units, visit the company’s website at www.idexcorp.com

About Mott

Mott is a leading microfiltration business specializing in the design, customization, and manufacturing of sintered porous metal components and engineered solutions used in fluidic applications. Mott combines design expertise for thousands of applications with the power of cutting-edge technology to create highly engineered products. Founded in 1959 in Farmington, CT, Mott is globally known for its reliability and unmatched dependability, serving the highest-cost of failure applications. With approximately 500 employees, Mott partners with world-class customers with demanding technical specifications to design, engineer, produce, and employ innovative products to solve their most challenging filtration and flow control problems.

Use of Non-GAAP Financial Information

IDEX prepares its public financial statements in conformity with accounting principles generally accepted in the United States of America (GAAP). IDEX supplements certain GAAP financial performance metrics with non-GAAP financial performance metrics. Management believes these non-GAAP financial performance metrics provide investors with greater insight, transparency and a more comprehensive understanding of the financial information used by management in its financial and operational decision-making because certain of these non-GAAP metrics exclude items not reflective of ongoing operations. Non-GAAP financial performance metrics should not be considered a substitute for, nor superior to, the financial data prepared in accordance with GAAP. EBITDA is calculated as net income plus interest expense plus provision for income taxes plus depreciation and amortization. EBITDA margin is calculated as EBITDA divided by net sales.

IDEX has not provided a reconciliation of Mott’s expected EBITDA and EBITDA margin for fiscal year 2024 or 2025 because we are unable to quantify certain amounts that would be required to be included in Mott’s contribution to net income without unreasonable efforts. In addition, IDEX believes such reconciliation would imply a degree of precision that would be confusing or misleading to investors.

Cautionary Note Regarding Forward-Looking Statements

This press release contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Such forward-looking statements include statements regarding the expected benefits of the acquisition of Mott, the expected impact of the acquisition on IDEX’s product offerings or proposed product offerings, IDEX’s combined existing and new customers and access to high-value end markets, the enhancement of IDEX’s business strategy, integration plans, the expected growth opportunities, profitability and synergies resulting from the acquisition, including the timing of such expected synergies, the present value of expected tax benefits, the anticipated long-term value to IDEX’s shareholders, the projected revenue, EBITDA and EBITDA margin of Mott and the related impact and timing for such impact on IDEX’s earnings, return on invested capital, and the expected timing for the closing of the transaction. These statements are subject to inherent uncertainties and risks that could cause actual results to differ materially from those anticipated at the date of this press release. The risks and uncertainties include, but are not limited to, the following: levels of industrial activity and economic conditions in the U.S. and other countries around the world, including uncertainties in the financial markets; pricing pressures, including inflation and rising interest rates and other competitive factors and levels of capital spending in certain industries; the impact of catastrophic weather events, natural disasters and public health threats; economic and political consequences resulting from terrorist attacks and wars; risks relating to the satisfaction of the closing conditions set forth in the definitive agreement; IDEX’s ability to integrate Mott and to acquire, integrate and operate other acquired businesses on a profitable basis; cybersecurity incidents; the relationship of the U.S. dollar to other currencies and its impact on pricing and cost competitiveness; political and economic conditions in foreign countries in which IDEX operates; developments with respect to trade policy and tariffs; interest rates; capacity utilization and the effect this has on costs; labor markets; supply chain conditions; market conditions and material costs; risks related to environmental, social and corporate governance issues, including those related to climate change and sustainability; and developments with respect to contingencies, such as litigation and environmental matters.  Additional factors that could cause actual results to differ materially from those reflected in the forward-looking statements include, but are not limited to, the risks discussed in the “Risk Factors” section included in IDEX’s most recent annual report on Form 10-K and IDEX’s subsequent quarterly reports filed with the Securities and Exchange Commission (“SEC”) and the other risks discussed in IDEX’s filings with the SEC. The forward-looking statements included here are only made as of the date of this press release and management undertakes no obligation to publicly update them to reflect subsequent events or circumstances, except as may be required by law. Investors are cautioned not to rely unduly on forward-looking statements when evaluating the information presented here.

Investor Contact:

Wendy Palacios

Vice President, VP, FP&A and Investor Relations

(847) 457-3723

wpalacios@idexcorp.com

Media Contact:

Mark Spencer

Vice President, Global Communications

(847) 457-3793

mdspencer@idexcorp.com

IDEX Reports First Quarter Results and Confirms Full Year Guidance

News Release
April 23, 2024

First Quarter 2024 Highlights
(All comparisons are against the first quarter of 2023 unless otherwise noted)

  • Sales of $801 million, down 5% overall and 6% organically, in line with expectations
  • Reported diluted EPS of $1.60, down 13%, and adjusted diluted EPS of $1.88, down 10%,
    exceeding first quarter expectations
  • Strong operating cash flow of $157 million, up 6%; free cash flow of $137 million, up 13%

Full Year and Second Quarter 2024 Outlook

  • Full year organic sales growth is projected to be 0% to 2% over the prior year
  • Full year GAAP diluted EPS of $7.13 – $7.43 (adjusted diluted EPS of $8.15 – $8.45)
  • Second quarter organic sales are projected to decline 2% to 3% over the prior year period
  • Second quarter GAAP diluted EPS of $1.75 – $1.80 (adjusted diluted EPS of $2.00 – $2.05)

NORTHBROOK, IL, April 23, 2024 – IDEX Corporation (NYSE: IEX) today announced its financial
results for the three-month period ended March 31, 2024.

“Our IDEX teams delivered solid results in the first quarter, expanding margins within our Fluid & Metering Technologies and Fire & Safety / Diversified Products segments while driving strong cash flow across the company,” said Eric D. Ashleman, IDEX Corporation Chief Executive Officer and President.


“We experienced an encouraging lift in sequential orders from our core industrial and municipal markets
after an extended period of destocking. The Health & Science Technologies segment performed to
expectations, but there are differing rates of recovery within its targeted markets. We will deploy
resources accordingly to build momentum in these advantaged markets through the remainder of the
year.”


“We remain committed to creating superior long-term value by aggressively deploying resources to drive
growth both in our current businesses and acquiring new businesses in advantaged markets.

View Full Press Release

IDEX Reports Fourth Quarter and Full Year 2023 Results

News Release
February 6, 2024

Fourth Quarter Highlights
(All comparisons against the fourth quarter of 2022 unless otherwise noted)

  • Sales of $789 million, down 3% overall and 6% organically
  • Reported diluted EPS of $1.43, down 16%; adjusted diluted EPS of $1.83, down 9%
  • Strong operating cash flow of $201 million, up 20%; free cash flow of $179 million, up 22%
  • Completed acquisition of STC Material Solutions on December 14, 2023 for $202 million

Full Year Highlights
(All comparisons against full year 2022 unless otherwise noted)

  • Record reported sales of $3.3 billion, up 3% overall and down 1% organically
  • Record reported diluted EPS of $7.85, up 2%; record adjusted diluted EPS of $8.22, up 1%
  • Record operating cash flow of $717 million, up 29%; record free cash flow of $627 million, up 28%
  • Invested approximately $425 million for acquisitions, capital projects and share repurchases

NORTHBROOK, IL, FEBRUARY 6, 2024 – IDEX Corporation (NYSE: IEX) today announced its
financial results for the quarter and year ended December 31, 2023.

“IDEX businesses weathered an unprecedented year of global recalibration, which played out differently
across our segments. Our team’s agility and core execution capabilities, combined with the quality of our
underlying assets, enabled us to deliver strong results in a challenging environment,” said Eric D.
Ashleman, IDEX Corporation Chief Executive Officer and President.

“Now, the majority of our end markets are stable, supporting the early stages of focused organic growth
to drive our next chapter of outperformance. However, the timing of market recovery within our Life
Sciences and Analytical Instrumentation businesses remains uncertain, moderating our overall full year
growth outlook.”

“We continue to aggressively pursue inorganic opportunities within advantaged, fast-growing markets, as
demonstrated by our purchase of STC Material Solutions in December. Our funnel of potential
acquisitions is strong and our efforts are well supported by ample capacity on our balance sheet.”

2024 Outlook
Full year 2024 organic sales growth is projected to be 0% to 2% over the prior year, with GAAP diluted
EPS of $7.15 to $7.45 (adjusted diluted EPS of $8.15 to $8.45).
First quarter 2024 organic sales are projected to decline 6% to 7% from the prior year period, with GAAP
diluted EPS of $1.45 to $1.50 (adjusted diluted EPS of $1.70 to $1.75).

View the full report: https://investors.idexcorp.com/news-releases/news-release-details/idex-reports-fourth-quarter-and-full-year-2023-results

IDEX Completes STC Material Solutions Acquisition

News Release
December 14, 2023

IDEX today completed its previously-announced acquisition of STC Material Solutions (STC), an integrated provider of advanced material science solutions.

STC specializes in the design and manufacturing of technical ceramics and hermetic sealing products for the most extreme, mission critical applications. The company has relationships with leading manufacturers in the semiconductor, aerospace and defense, industrial technology, medical technology, and energy sectors. Headquartered in St. Albans, Vermont, STC also has operations in Santa Ana, California.

“STC Material Solutions fits our growth strategy well, with strong IDEX qualities, including great teams with technical and domain expertise who develop and build highly-engineered products that command a premium,” IDEX Chief Executive Officer and President Eric Ashleman said. “STC expands our growing material science expertise, affording opportunities to collaborate with other IDEX critical components businesses on comprehensive solution sets for customers.”

IDEX continues to put its strong balance sheet to work, prioritizing the identification and completion of high-quality acquisitions focused on expanding our expertise into dynamic markets that support our future vision and growth strategy.

IDEX purchased STC from Artemis for cash consideration of $206 million USD, subject to customary post-closing adjustments. IDEX funded the acquisition using cash on hand and proceeds from its revolving credit facility. STC will be included in the Health & Science Technologies (HST) segment.

IDEX Corporation Expanding Material Science Manufacturing Expertise with Acquisition of STC Material Solutions

News Release
October 30, 2023

Northbrook, Illinois, (October 30, 2023) – IDEX Corporation (NYSE:IEX) today announced that it has entered into a definitive agreement to acquire STC Material Solutions (“STC”), an integrated provider of advanced material science solutions, from Artemis for cash consideration of $206 million USD, subject to customary post-closing adjustments.

STC specializes in the design and manufacturing of technical ceramics and hermetic sealing products for the most extreme, mission critical applications. The company has relationships with leading manufacturers in the semiconductor, aerospace and defense, industrial technology, medical technology, and energy sectors. Headquartered in St. Albans, Vermont, STC also has operations in Santa Ana, California (USA).

“STC Material Solutions expands our growing expertise in material sciences and offers significant opportunities to collaborate with other IDEX critical components businesses on comprehensive solution sets for customers,” IDEX Chief Executive Officer and President Eric Ashleman said. “We see STC as an excellent fit with our growth strategy, possessing IDEX qualities throughout, including highly-engineered products developed and built with expertise that commands a premium.”

“We continue to prioritize the identification and completion of high-quality acquisitions like this. Our extended M&A team has developed a strong funnel of excellent prospective additions that will continue to put our strong balance sheet to work,” Ashleman said.

STC is expected to generate approximately $50 million in revenue in 2024, with IDEX-like margins and will be included in the Health & Science Technologies (HST) segment.

IDEX expects the transaction to close by late-2023, subject to regulatory approvals. This acquisition is expected to be funded by IDEX using cash on hand and proceeds from its revolving credit facility.

Cautionary Note Regarding Forward-Looking Statements

This press release contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Such forward-looking statements include statements regarding the expected benefits of the acquisition of STC, the expected impact of the acquisition on IDEX’s product offerings or proposed product offerings and pricing, the enhancement of IDEX’s business strategy, integration plans, the expected growth opportunities and synergies resulting from the acquisition, the projected earnings and margins of STC and the related impact on IDEX’s earnings, future acquisitive behavior and pipeline of IDEX, and the expected timing and funding for the closing of the acquisition, and are indicated by words or phrases such as “anticipates,” “estimates,” “plans,” “expects,” “projects,” “forecasts,” “should,” “could,”

“will,” “management believes,” “the Company believes,” “the Company intends” and similar words or phrases. These statements are subject to inherent uncertainties and risks that could cause actual results to differ materially from those anticipated at the date of this press release. The risks and uncertainties include, but are not limited to, the following: levels of industrial activity and economic conditions in the U.S. and other countries around the world, including uncertainties in the financial markets and adverse developments affecting the financial services industry; pricing pressures, including inflation and rising interest rates, and other competitive factors and levels of capital spending in certain industries, all of which could have a material impact on order rates and IDEX’s results; the impact of health epidemics and pandemics and terrorist attacks and wars, which could have an adverse impact on IDEX’s business by creating disruptions in the global supply chain and by potentially having an adverse impact on the global economy; IDEX’s ability to make acquisitions and to integrate and operate acquired businesses on a profitable basis; the relationship of the U.S. dollar to other currencies and its impact on pricing and cost competitiveness; political and economic conditions in foreign countries in which IDEX operates; developments with respect to trade policy and tariffs; capacity utilization and the effect this has on costs; labor markets; supply chain conditions; market conditions and material costs; risks related to environmental, social and corporate governance issues, including those related to climate change and sustainability; and developments with respect to contingencies, such as litigation and environmental matters. Additional factors that could cause actual results to differ materially from those reflected in the forward-looking statements include, but are not limited to, the risks discussed in the “Risk Factors” section included in IDEX’s most recent annual report on Form 10-K and IDEX’s subsequent quarterly reports filed with the Securities and Exchange Commission (“SEC”) and the other risks discussed in IDEX’s filings with the SEC. The forward-looking statements included here are only made as of the date of this press release, and management undertakes no obligation to publicly update them to reflect subsequent events or circumstances, except as may be required by law. Investors are cautioned not to rely unduly on forward-looking statements when evaluating the information presented here.

About IDEX

IDEX Corporation (NYSE: IEX) makes thousands of products and mission-critical components that improve everyday life all around you. If you enjoy chocolate, it quite possibly passed through a Viking® internal gear pump at the candy factory. If you were ever in a car accident, emergency workers may have used the Hurst Jaws of Life® rescue tool to save your life. If your doctor ordered a DNA test to predict your risk of disease or determine a course of treatment, the lab may have used equipment containing components made by IDEX Health & Science. Founded in 1988 with three small, entrepreneurial manufacturing companies, we’re proud to say that we now call over 50 diverse businesses around the world part of the IDEX family. With more than 8,500 employees and manufacturing operations in more than 20 countries, IDEX is a high-performing, global company with over $3.1 billion in annual sales, committed to making trusted solutions that improve lives. IDEX shares are traded on the New York Stock Exchange under the symbol “IEX”.

For further information on IDEX Corporation and its business units, visit the company’s website at www.idexcorp.com.

Investor Contact

IDEX Corporation Allison Lausas

Vice President, Chief Accounting Officer and Interim Chief Financial Officer

+1 847-498-7070

investorrelations@idexcorp.com

Media Contact:

IDEX Corporation

Mark Spencer

+1 847-457-3793 mdspencer@idexcorp.com

IDEX Names Abhi Khandelwal as SVP, Chief Financial Officer

News Release
October 25, 2023

NORTHBROOK, IL (October 25, 2023) – IDEX Corporation (NYSE:IEX) today announced the appointment of Abhi Khandelwal as Senior Vice President and Chief Financial Officer of the Company, effective November 20, 2023.

Mr. Khandelwal returns to IDEX where he served from 2010 to early 2020 in a number of financial roles of increasing responsibility, most recently as Vice President of Finance Operations, Treasury and Financial Planning & Analysis. He joins IDEX after serving as Chief Financial Officer of Multi-Color Corporation, a global packaging services and label solutions provider based in Rosemont, Illinois since January 2022, and, prior to that, as Senior Vice President and Chief Financial Officer for CIRCOR International.

Prior to his initial service with IDEX, Mr. Khandelwal held a range of financial leadership positions at Stanley Black & Decker and General Electric. He earned a Bachelor of Science degree in Finance from Indiana University and a Master of Business Administration degree from Northwestern University.

“We are thrilled to welcome Abhi back to IDEX, where he will be able to leverage his CFO experience along with his successful prior history with our organization and our people. He was a trusted financial partner to me in my earlier role as COO, and I look forward to his expertise and partnership in helping IDEX continue to grow,” IDEX CEO and President Eric Ashleman said.

Allison Lausas, who has served as the Company’s interim Chief Financial Officer since September 2023, will cease serving as interim Chief Financial Officer as of the effective date of Mr. Khandelwal’s appointment, and will continue in her position as Vice President and Chief Accounting Officer. Mr. Ashleman stated, “I want to thank Allison for her outstanding leadership in this interim period and for the talent and leadership she brings to our finance team overall. We are fortunate to have her on the team, and I am very appreciative of her contributions to IDEX, especially in this time of transition.”

About IDEX

IDEX (NYSE: IEX) makes thousands of products and mission-critical components that improve everyday life all around you. If you enjoy chocolate, it quite possibly passed through a Viking® internal gear pump at the candy factory. If you were ever in a car accident, emergency workers may have used the Hurst Jaws of Life® rescue tool to save your life. If your doctor ordered a DNA test to predict your risk of disease or determine a course of treatment, the lab may have used equipment containing components made by IDEX Health & Science. Founded in 1988 with three small, entrepreneurial manufacturing companies, we’re proud to say that we now call over 50 diverse businesses around the world part of the IDEX family. With more than 8,500 employees and manufacturing operations in more than 20 countries, IDEX is a high-performing, global company with over $3.1 billion in annual sales, committed to making trusted solutions that improve lives. IDEX shares are traded on the New York Stock Exchange under the symbol “IEX.”

For further information on IDEX Corporation and its business units, visit the company’s website at www.idexcorp.com.

Investor Contact:
IDEX Corporation
Allison Lausas
Vice President and Chief Accounting Officer
+1 847-498-7070
investorrelations@idexcorp.com

Media Contact:
IDEX Corporation
Mark Spencer
+1 847-457-3793
mdspencer@idexcorp.com

WordPress Lightbox